![]() A key contribution of Medicago to the COVID-19 pandemic response was the licensing in Canada of a virus-like particle vaccine (Covifenz) in under 24 months from initial design. ![]() ![]() Medicago has been a pioneer and a leader in the commercial development of plant molecular farming, particularly vaccine production by transient expression in Nicotiana benthamiana (tobacco). This field was recently surprised by the announcement that the Canadian biotechnology company Medicago has ceased operations owing to the termination of investment by its parent company 3. Plant molecular farming, which includes the production of recombinant proteins and small molecules using plant biotechnology, could provide a step change in improving health outcomes, particularly in developing countries 1, 2.
0 Comments
Leave a Reply. |